MAFLD
Clinical trials for MAFLD explained in plain language.
Never miss a new study
Get alerted when new MAFLD trials appear
Sign up with your email to follow new studies for MAFLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested for dual threat: diabetes and fatty liver
Disease control Not yet recruitingThis study is testing whether adding a medication called alogliptin to a standard two-drug diabetes pill (pioglitazone + metformin) works better for people who have both type 2 diabetes and fatty liver disease. Researchers will enroll 80 participants to see if the three-drug comb…
Matched conditions: MAFLD
Phase: PHASE4 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
One pill, two problems: daily drug trial aims to halt silent organ damage
Disease control Not yet recruitingThis study is testing whether a daily pill called oral semaglutide can slow down or prevent worsening kidney disease in people who also have fatty liver disease (MAFLD). It will involve 90 adults with both conditions, who will be randomly assigned to receive either the pill plus …
Matched conditions: MAFLD
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Ancient Herb's modern derivative targets silent liver epidemic
Disease control Not yet recruitingThis study is testing whether a drug called diacerein can help treat metabolic fatty liver disease (MAFLD), a common condition where fat builds up in the liver. Researchers will give either diacerein or a placebo (inactive pill) to 74 adults with MAFLD to see if the drug reduces …
Matched conditions: MAFLD
Phase: NA • Sponsor: Hongyan Wu • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New handheld device could make liver testing easier
Diagnosis Not yet recruitingThis study compares two portable devices that measure liver stiffness and fat without needles or surgery. Researchers will test 224 adults with chronic liver disease from hepatitis B or fatty liver disease. They'll compare measurements taken while lying down versus sitting up to …
Matched conditions: MAFLD
Sponsor: Hong You • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC